CCR4 — Drug Target

All drugs that target CCR4 — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

CCR4 antagonist

Phase 3 pipeline (1)

• MK0831 · Merck Sharp & Dohme LLC · CCR4 antagonist · Oncology
  MK0831 is a selective antagonist of the chemokine receptor CCR4 that reduces the recruitment and activation of T regulatory cells and other immune cells to the tumor microenvironment.

Phase 2 pipeline (1)

• CCX-354-C · Amgen · CCR4 antagonist · Immunology
  CCX-354-C is a C-C chemokine receptor 4 (CCR4) antagonist that blocks immune cell recruitment to reduce inflammatory responses.